Literature DB >> 28974596

New horizons in multimodality molecular imaging and novel radiotracers.

Sally Barrington1, Philip Blower2, Gary Cook3.   

Abstract

Positron emission tomography (PET)/computerised tomography is now established in clinical practice for oncologic and non-oncological applications. Improvement and development of scanner hardware has allowed faster acquisitions and wider application. PET/magnetic resonance imaging offers potential improvements in diagnostic accuracy and patient acceptability but clinical applications are still being developed. A range of new radiotracers and non-radioactive contrast agents is likely to lead to a growth in hybrid molecular imaging applications that will allow better characterisation of disease processes. © Royal College of Physicians 2017. All rights reserved.

Entities:  

Keywords:  Computerised tomography; contrast agents; magnetic resonance imaging; optical imaging; positron emission tomography

Mesh：

Substances：

Year:  2017        PMID： 28974596      PMCID： PMC6301925          DOI： 10.7861/clinmedicine.17-5-444

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


  18 in total

1.  Letter from the editors: Theranostics.

Authors:  Leonard M Freeman; M Donald Blaufox
Journal:  Semin Nucl Med       Date:  2012-05       Impact factor: 4.446

2.  Multimodal Surgical Guidance during Sentinel Node Biopsy for Melanoma: Combined Gamma Tracing and Fluorescence Imaging of the Sentinel Node through Use of the Hybrid Tracer Indocyanine Green-(99m)Tc-Nanocolloid.

Authors:  Nynke S van den Berg; Oscar R Brouwer; Boudewijn E Schaafsma; Hanna M Mathéron; W Martin C Klop; Alfons J M Balm; Harm van Tinteren; Omgo E Nieweg; Fijs W B van Leeuwen; Renato A Valdés Olmos
Journal:  Radiology       Date:  2014-12-17       Impact factor: 11.105

3.  Bimodal MR-PET agent for quantitative pH imaging.

Authors:  Luca Frullano; Ciprian Catana; Thomas Benner; A Dean Sherry; Peter Caravan
Journal:  Angew Chem Int Ed Engl       Date:  2010-03-22       Impact factor: 15.336

Review 4.  Whole-body diffusion-weighted MR imaging in cancer: current status and research directions.

Authors:  Anwar R Padhani; Dow-Mu Koh; David J Collins
Journal:  Radiology       Date:  2011-12       Impact factor: 11.105

5.  (⁹⁹m)Tc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging.

Authors:  Rafael Torres Martin de Rosales; Richard Tavaré; Arnaud Glaria; Gopal Varma; Andrea Protti; Philip J Blower
Journal:  Bioconjug Chem       Date:  2011-02-21       Impact factor: 4.774

Review 6.  Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials.

Authors:  M O Leach; K M Brindle; J L Evelhoch; J R Griffiths; M R Horsman; A Jackson; G Jayson; I R Judson; M V Knopp; R J Maxwell; D McIntyre; A R Padhani; P Price; R Rathbone; G Rustin; P S Tofts; G M Tozer; W Vennart; J C Waterton; S R Williams; P Workman
Journal:  Br J Radiol       Date:  2003       Impact factor: 3.039

7.  Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.

Authors:  John Radford; Tim Illidge; Nicholas Counsell; Barry Hancock; Ruth Pettengell; Peter Johnson; Jennie Wimperis; Dominic Culligan; Bilyana Popova; Paul Smith; Andrew McMillan; Alison Brownell; Anton Kruger; Andrew Lister; Peter Hoskin; Michael O'Doherty; Sally Barrington
Journal:  N Engl J Med       Date:  2015-04-23       Impact factor: 91.245

8.  A whole-body dual-modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment response in different microenvironments.

Authors:  Gilbert O Fruhwirth; Seckou Diocou; Philip J Blower; Tony Ng; Greg E D Mullen
Journal:  J Nucl Med       Date:  2014-03-06       Impact factor: 10.057

9.  Synthesis of 64Cu(II)-bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: in vivo evaluation as dual-modality PET-MRI agent.

Authors:  Rafael Torres Martin de Rosales; Richard Tavaré; Rowena L Paul; Maite Jauregui-Osoro; Andrea Protti; Arnaud Glaria; Gopal Varma; Istvan Szanda; Philip J Blower
Journal:  Angew Chem Int Ed Engl       Date:  2011-05-04       Impact factor: 15.336

10.  Al(OH)3 facilitated synthesis of water-soluble, magnetic, radiolabelled and fluorescent hydroxyapatite nanoparticles.

Authors:  X Cui; M A Green; P J Blower; D Zhou; Y Yan; W Zhang; K Djanashvili; D Mathe; D S Veres; K Szigeti
Journal:  Chem Commun (Camb)       Date:  2015-06-07       Impact factor: 6.222
View more
  2 in total

Review 1.  Total-Body PET Imaging of Musculoskeletal Disorders.

Authors:  Abhijit J Chaudhari; William Y Raynor; Ali Gholamrezanezhad; Thomas J Werner; Chamith S Rajapakse; Abass Alavi
Journal:  PET Clin       Date:  2021-01

2.  [18F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [18F]FDG in human xenograft models.

Authors:  Narinée Hovhannisyan; Fabien Fillesoye; Stéphane Guillouet; Méziane Ibazizene; Jérôme Toutain; Fabienne Gourand; Samuel Valable; Benoit Plancoulaine; Louisa Barré
Journal:  Theranostics       Date:  2018-08-10       Impact factor: 11.556
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.